STOCK TITAN

Aveanna Healthcare Holdings, Inc. SEC Filings

AVAH NASDAQ

Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.

Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Aveanna Healthcare Holdings Inc. has completed its acquisition of Family First Homecare, a multi-state pediatric home care provider with 27 locations across seven states. The company paid a cash purchase price of $175.5 million, funded entirely with cash on hand, to acquire all membership interests of Family First Holding, LLC.

Following this deal, Aveanna updated its full fiscal year 2026 outlook to reflect Family First’s contribution. Revenue guidance increased to $2.63–$2.65 billion, up from $2.56–$2.58 billion, driven by Family First’s revenue guidance of $70.0 million. Adjusted EBITDA guidance rose to $338–$342 million, from $328–$332 million, reflecting Family First’s Adjusted EBITDA guidance of $10.0 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3%
Tags
current report
-
Rhea-AI Summary

Aveanna Healthcare Holdings Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 29, 2026. Stockholders elected three Class II directors—Rodney D. Windley, Sam Weil, and Steven E. Rodgers—to three-year terms ending at the 2029 Annual Meeting.

Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending January 2, 2027, with 198,808,170 votes for and 477,379 against. Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 160,094,458 votes for and 19,490,871 against. No other matters were considered.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Aveanna Healthcare Holdings Inc. announced that its subsidiary Aveanna Healthcare LLC has repriced its first lien credit and revolving credit facilities. The amendment refinances outstanding senior secured term loans with new 2026 Term Loans totaling $1,318,375,000 and renews a $250,000,000 senior secured revolving credit facility.

The 2026 Facilities reduce applicable interest rate margins by 0.50 percentage points. Both the term loans and revolver now bear interest at, at the borrower’s election, Term SOFR plus a 3.25% margin or a base rate plus a 2.25% margin. Margins may be reduced by an additional 0.25 percentage points if the borrower obtains a rating of at least B2 or B from specified credit rating agencies, while other key credit agreement terms remain largely unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
current report
Rhea-AI Summary

Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported an open-market sale of 125,000 shares of common stock at a weighted average price of $7.5883 per share. The sale occurred on May 20, 2026 and reflects a discretionary transaction in the market.

Following this sale, Cunningham directly holds 212,755 shares of Aveanna common stock. The reported price range for the trades was between $7.50 and $7.69 per share, based on multiple individual transactions combined into the disclosed weighted average price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AVAH filed a Form 144 reporting proposed sales of Common Stock and listing restricted stock vesting events under a registered plan. The filing lists 125,000 shares alongside a dollar figure $948,537.50 and the entry 217,755,203 with date 05/20/2026. The filing also itemizes restricted stock vesting: 75,406 shares on 06/05/2025, 38,985 shares on 12/29/2025, and 10,609 shares on 02/14/2026, each described as "Restricted stock vesting under a registered plan" and labeled "Services Rendered."

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Aveanna Healthcare Holdings Inc. furnished an investor presentation outlining 2026 guidance and strong early-year performance. The company targets $2.56–$2.58 billion in 2026 revenue and $328–$332 million in Adjusted EBITDA, supported by a national platform of 379 locations across 39 states and 29,000 caregivers.

For Q1 2026, revenue reached $647.9 million, up 15.9% year over year, while Adjusted EBITDA rose to $84.4 million, a 25.2% increase. Net income improved to $41.7 million, and operating cash flow turned positive at $4.3 million, a $12.9 million improvement versus Q1 2025.

The presentation highlights segment growth in Private Duty Services, Home Health & Hospice, and Medical Solutions, along with a focus on value-based agreements and preferred payor relationships. Aveanna reports liquidity of $524.8 million against total variable-rate debt of $1,483 million, with interest rate swaps and caps in place, and free cash flow of $(3.8) million for Q1 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Aveanna Healthcare Holdings reported strong first-quarter 2026 results, with revenue of $647.9 million, up 15.9% from $559.2 million a year earlier. Net income rose to $41.7 million from $5.2 million, and diluted earnings per share increased to $0.19 from $0.03.

Growth was broad-based: Private Duty Services revenue grew 16.4%, Home Health & Hospice 17.4%, and Medical Solutions 7.4%. Field contribution improved to $109.6 million, or 16.9% of revenue, helped by lower branch and regional administrative expenses as a percentage of revenue.

The company generated $4.3 million of operating cash flow, ending the quarter with $189.3 million in cash and cash equivalents. Long-term obligations totaled $1.32 billion, primarily 2025 Term Loans accruing interest at 7.42%, and the $165.0 million Securitization Facility carried a 6.26% rate.

Aveanna also advanced its growth strategy with a pending $175.5 million cash acquisition of Family First Holding, LLC, a multi-state pediatric home care provider, expected to close in the second fiscal quarter of 2026 and funded with cash on hand and its Securitization Facility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.9%
Tags
quarterly report

FAQ

How many Aveanna Healthcare Holdings (AVAH) SEC filings are available on StockTitan?

StockTitan tracks 98 SEC filings for Aveanna Healthcare Holdings (AVAH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aveanna Healthcare Holdings (AVAH)?

The most recent SEC filing for Aveanna Healthcare Holdings (AVAH) was filed on June 3, 2026.